Dear M.W.: Stevia is a natural extract of the Stevia rebaudiana plant. The raw leaves are not considered safe, but purified ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

Discover how modern diabetes medications offer cardiovascular benefits, transforming diabetes care and improving outcomes worldwide.

Eli Lilly's profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, banking on the launch of its popular ...

At CommunityHealth, which serves a large immigrant population, prescriptions for diabetes, high blood pressure and other ...

Although Mounjaro and Zepbound have been headlining Lilly’s financial reports in recent years, the company’s roster of non-incretin products, which grew sales 20% in the fourth quarter, should “help ...

Millions with type 2 diabetes face hidden nutrient deficiencies, raising concerns about health risks and the urgent need for dietary intervention.

A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people ...

On an adjusted basis, the U.S. drugmaker expects to earn between $22.50 and $24.00 per share in 2025. Analysts were expecting ...